Markers of prothrombotic state of patients recovered after COVID-19
The Ukrainian Biochemical Journal · 03.08.2026 · 98 (4) · 75-85
DOI: 10.15407/ubj98.04.075 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Ukrainian Biochemical Journal, online erschienen am 03.08.2026. Verfasst von D. S. Korolova und 12 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
In recent period the attention of scientists and doctors was focused mainly on methods of COVID-19 treatment. However, clinical course of coronavirus disease strongly affects blood coagulation with the tendency for venous and arterial thrombosis, leading to long-term imbalance between coagulation and anticoagulation systems, which can cause serious danger for health of post-COVID-19 (PCD) patients.
Objective
In our work we focused on the analysis of the molecular markers of hemostasis system activation in blood plasma of patients recovered after COVID-19.
Methods
Blood plasma samples of 119 seropositive patients recovered from COVID-19 were analysed. The patients were divided into a high-risk group (HRG, n = 163) and a non-risk group (NRG, n = 28) according to WHO recommendations. Patients were examined in a recovery time scale of 1-30; 31-60 days and more than 2 months. Blood plasma samples of seronegative healthy volunteers were collected as the reference group (n = 19). The concentration of soluble fibrin (SF) and D-dimer was measured with sandwich ELISA, generation of activated protein C (PC) and prethrombin-1 (Pre-1)) level with assay using specific chromogenic substrates, and fibrinogen concentration with spectrophotometric method after initiation of coagulation by Ancistron-H.
Results
Concentration of fibrinogen, SF and Pre-1 were increased in a blood plasma of patients of NRG and HRG groups in comparison to the reference group. Increasing of fibrinogen and Pre-1 concentrations correlated with COVID-19 stage. The fibrinogen and SF concentrations remained high more than 2 months after recovery in HRG group and elevated after 2 months after recovery in NRG group. D-dimer and protein C levels were elevated in 8% and 11% of PCD patients respectively.
Conclusions
Long-term prethrombotic state was more expressed in HRG group of PCD patients. Monitoring of the main coagulation markers can indicate the risk of intravascular thrombus formation in PCD patients. SF, Pre-1 and elevated fibrinogen concentrations were selected as useful thrombosis markers in PCD patients. Keywords: coagulation, COVID-19 patients, D-dimer, fibrinogen, protein C, soluble fibrin, thrombosis
Zitieren
APA
Korolova, D. S., Shevchuk, O. O., Kostiuchenko, O. P., Chernyshenko, T. M., Klymenko, K. P., Platonova, T. M., Ivankiv, Y. I., Paliy, S. M., Voitovych, A. I., Chernyshenko, V. O., Korda, M. M., Komisarenko, S. V., & Vari, S. G. (2026). Markers of prothrombotic state of patients recovered after COVID-19. The Ukrainian Biochemical Journal, 98(4), 75-85. https://doi.org/10.15407/ubj98.04.075
Vancouver
Korolova DS, Shevchuk OO, Kostiuchenko OP, Chernyshenko TM, Klymenko KP, Platonova TM, et al. Markers of prothrombotic state of patients recovered after COVID-19. The Ukrainian Biochemical Journal. 2026;98(4):75-85. doi:10.15407/ubj98.04.075
BibTeX
@article{Korolova2026,
author = {Korolova, D. S. and Shevchuk, O. O. and Kostiuchenko, O. P. and Chernyshenko, T. M. and Klymenko, K. P. and Platonova, T. M. and Ivankiv, Ya. I. and Paliy, S. M. and Voitovych, A. I. and Chernyshenko, V. O. and Korda, M. M. and Komisarenko, S. V. and Vari, S. G.},
title = {Markers of prothrombotic state of patients recovered after COVID-19},
journal = {The Ukrainian Biochemical Journal},
year = {2026},
volume = {98},
number = {4},
pages = {75--85},
doi = {10.15407/ubj98.04.075}
}
EUVIMED